AIM IMMUNOTECH INC. Payments for Construction in Process
AIM IMMUNOTECH INC. (AIM) reported Payments for Construction in Process of $7.73 million for the 19-month period ending 2013-06-30, per its 10-Q filed 2013-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForConstructionInProcess · last filed 2013-11-08
- 2013-06-30: Payments for Construction in Process 19 month $7.73M; Payments for Construction in Process 19 month as first filed $7.71M.
- 2013-03-31: Payments for Construction in Process 16 month $7.49M.
- 2012-12-31: Payments for Construction in Process 13 month $7.05M.
| Period end | Payments for Construction in Process 13 month | Payments for Construction in Process 16 month | Payments for Construction in Process 19 month | Payments for Construction in Process 19 month as first filed |
|---|---|---|---|---|
| 2013-06-30 | $7.73M 10-Q · filed 2013-11-08 | $7.71M 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | $7.49M 10-Q · filed 2013-05-08 | |||
| 2012-12-31 | $7.05M 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |